North Star Investment Management’s Viking Therapeutics VKTX Stock Holding History

North Star Investment Management’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$119K	Hold	3,058	–	–	0.01%	577
2026 Q1	$99.5K	Buy	3,058 +1,485	+94%	+$47.7K	0.01%	604
2025 Q4	$55.3K	Sell	1,573 -1,442	-48%	-$51.1K	﹤0.01%	652
2025 Q3	$79.2K	Sell	3,015 -500	-14%	-$14.9K	0.01%	571
2025 Q2	$93.1K	Sell	3,515 -800	-19%	-$21.1K	0.01%	532
2025 Q1	$104K	Sell	4,315 -300	-7%	-$9.48K	0.01%	504
2024 Q4	$186K	Buy	4,615 +200	+5%	+$11.4K	0.01%	425
2024 Q3	$280K	Buy	4,415 +2,090	+90%	+$123K	0.02%	371
2024 Q2	$123K	Buy	2,325 +525	+29%	+$34.4K	0.01%	467
2024 Q1	$148K	Buy	+1,800	New	+$80.1K	0.01%	462

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

North Star Investment Management's VKTX Position: Q2 2026 in Review

North Star Investment Management held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 3,058 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #577.

North Star Investment Management first reported a position in VKTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $280K in Q3 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

North Star Investment Management held 3,058 shares of Viking Therapeutics worth $119K as of Q2 2026.
North Star Investment Management left its Viking Therapeutics share count unchanged in Q2 2026.
Viking Therapeutics made up 0.01% of North Star Investment Management's portfolio in Q2 2026, its #577 holding.
North Star Investment Management first reported a position in Viking Therapeutics in Q1 2024 and has held it in 10 quarters since.
North Star Investment Management's Viking Therapeutics position peaked at $280K in Q3 2024.
436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.